Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19.
Clinical trial NCT04952805 · UNKNOWN
Trial details
- NCT number
- NCT04952805
- Sponsor
- Toscana Life Sciences Sviluppo s.r.l.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-06
- Primary completion
- 2022-03-31
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.